Feasibility of Planned modified Regional Pancreatoduodenectomy for Pancreatic Head Ductal Adenocarcinoma

Feasibility of Planned modified Regional Pancreatoduodenectomy for Pancreatic Head Ductal Adenocarcinoma - Feasibility of Pl-mRPD for PhDAC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051375

Enrollment

Registered

2023-06-20

Start date

2021-08-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eligibility included histologically proven resectable (R) or borderline resectable (BR) pancreatic ductal adenocarcinoma with contact of SMV/PV. Exclusion criteria was liver/lung metastasis, para-aortic lymph node metastasis positive or peritoneal metastasis.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility included histologically proven resectable (R) or borderline resectable (BR) pancreatic ductal adenocarcinoma with contact of SMV/PV.

Exclusion criteria

Exclusion criteria: Exclusion criteria was lung and liver metastasis, para-aortic lymph node metastasis positive, lavage cytology positive or peritoneal metastasis.

Design outcomes

Primary

Measure	Time frame
The primary endpoint was feasibility rate of preoperative planned portal vein resection.	—

Secondary

Measure	Time frame
The secondary endpoint was safety including operative outcomes (duration of surgery, blood loss and transfusion) and postoperative outcomes (in-hospital mortality and morbidity, pathological findings, patency rate of portal vein).	—

Countries

Japan

Contacts

Public ContactMuga Terasawa

Juntendo University School of Medicine Department of Hepatobiliary-Pancreatic Surgery

m_terasawa2000@yahoo.co.jp0338133111

Outcome results